CLIN MOL HEPATOL 潤色咨詢

Clinical and Molecular Hepatology

出版年份:暫無數(shù)據(jù) 年文章數(shù):242 投稿命中率: 開通期刊會員,數(shù)據(jù)隨心看

出版周期:Q 自引率:暫無數(shù)據(jù) 審稿周期: 開通期刊會員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費用
暫無數(shù)據(jù)
版面費用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量14.38% (2022年為12.33%)
自引率
暫無數(shù)據(jù)
年文章數(shù)
242
期刊官網(wǎng)
點擊查看 (點擊次數(shù):1590)
投稿鏈接
點擊查看 (點擊次數(shù):1114次)
作者需知
點擊查看 (點擊次數(shù):595次)
偏重的研究方向
暫無數(shù)據(jù)
期刊簡介
稿件收錄要求

Clinical and Molecular Hepatology (Clin Mol Hepatol), is an international, peer-reviewed, open- access journal published quarterly in English.?Clin Mol Hepatol?aims to share advanced and latest knowledge, trend, and understanding of hepatobiliary diseases, to provide a wide open academic forum for active debate and discussion among clinical doctors, translational researchers, and basic scientists, and to improve public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific area with high prevalence of B viral infection and hepatocellular carcinoma. In addition,?Clin Mol Hepatol?gives priority to epidemiological studies of hepatobiliary diseases in East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America.

Clin Mol Hepatol?publishes original papers, meta-analysis, letter to editor, case reports, reviews, guidelines, editorials, and liver image and pathology on all aspects of the field of hepatology.

《臨床與分子肝病學(xué)》是一本國際性、同行評議、開放獲取的英文季刊。《臨床與分子肝病學(xué)》旨在分享肝膽疾病方面的先進和最新知識、趨勢和理解,為臨床醫(yī)生、轉(zhuǎn)化研究人員和基礎(chǔ)科學(xué)家之間的積極辯論和討論提供一個廣闊的開放的學(xué)術(shù)論壇,并通過多學(xué)科方法改善公共衛(wèi)生,特別是在資源有限的乙型病毒感染和肝細胞癌高發(fā)的亞太地區(qū)。此外,《臨床與分子肝病學(xué)》優(yōu)先考慮東亞、北亞、東南亞、中亞、南亞、西南亞、太平洋、非洲、中歐、東歐、中美洲和南美洲的肝膽疾病流行病學(xué)研究?!?/span>

臨床與分子肝病學(xué)》發(fā)表有關(guān)肝病學(xué)領(lǐng)域各個方面的原創(chuàng)論文、薈萃分析、致編輯的信、病例報告、評論、指南、社論以及肝臟圖像和病理學(xué)。